SeraCare Life Sciences, Inc. today announced that the Company will present at the UBS Global Life Science Conference on Thursday, September 25, 2008 at 2:00 PM Eastern Time at the Grand Hyatt in New York City. Susan Vogt, President and CEO of SeraCare, will present an overview of the Company’s business strategy, including core products and services and key initiatives that directly support SeraCare’s global growth strategy. SeraCare serves the global life sciences industry by providing vital products and services to facilitate the discovery, validation and production of human diagnostics and therapeutics.
The presentation will be webcast live at: www.ibb.ubs.com and will be archived until October 25, 2008. To access the live webcast, click the "Conferences" icon in the center right of the webpage and follow the link for the webcast next to the "Global Life Sciences” Conference heading. The webcast will also be available in the "Investor Relations" section of the Company's website, www.seracare.com.
About SeraCare Life Sciences:
SeraCare serves the global life sciences industry by providing vital products and services to facilitate the discovery, validation and production of human diagnostics and therapeutics. SeraCare’s innovative portfolio includes diagnostic controls, plasma-derived reagents and molecular biomarkers, biobanking and contract research services. SeraCare's quality systems, scientific expertise and state-of-the-art facilities support its customers in meeting the stringent requirements of the highly regulated life sciences industry.
Contact:
SeraCare Life Sciences, Inc.
Gregory A. Gould, 508-244-6400
Chief Financial Officer
or
Investor Relations
MacDougall Biomedical Communications
Sarah Cavanaugh, 781-235-3060
Source: SeraCare Life Sciences, Inc.
The presentation will be webcast live at: www.ibb.ubs.com and will be archived until October 25, 2008. To access the live webcast, click the "Conferences" icon in the center right of the webpage and follow the link for the webcast next to the "Global Life Sciences” Conference heading. The webcast will also be available in the "Investor Relations" section of the Company's website, www.seracare.com.
About SeraCare Life Sciences:
SeraCare serves the global life sciences industry by providing vital products and services to facilitate the discovery, validation and production of human diagnostics and therapeutics. SeraCare’s innovative portfolio includes diagnostic controls, plasma-derived reagents and molecular biomarkers, biobanking and contract research services. SeraCare's quality systems, scientific expertise and state-of-the-art facilities support its customers in meeting the stringent requirements of the highly regulated life sciences industry.
Contact:
SeraCare Life Sciences, Inc.
Gregory A. Gould, 508-244-6400
Chief Financial Officer
or
Investor Relations
MacDougall Biomedical Communications
Sarah Cavanaugh, 781-235-3060
Source: SeraCare Life Sciences, Inc.
0 comments:
Post a Comment